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Abstract
We investigate the relationship between costs and quality in non-
prot nursing homes, a key issue in the present context of cost contain-
ment measures. In accordance with the economic theory of production,
we estimate a three-inputs total cost function for nursing home ser-
vices using data from 45 nursing homes in Switzerland between 2006
and 2010. Quality is measured by means of clinical indicators regard-
ing process and outcome derived from the Minimum Data Set. We
consider both composite and single quality indicators. Contrary to
previous studies, we use panel data and control for unobserved het-
erogeneity. This allows to capture nursing homes specic features that
may explain di¤erences in structural quality or costs levels. We nd
evidence that poor levels of quality regarding outcome, as measured
by the prevalence of severe pain and weight loss, lead to higher costs.
Our results are robust to quality endogeneity concerns.
Keywords: nursing home costs, nonprot, quality indicators, cost-
quality tradeo¤
JEL classication: I10, L3.
Institute for Health Metrics and Evaluation (IHME), University of Washington, United
States; Institute of Economics (IdEP), Università della Svizzera italiana (USI), Switzer-
land. Corresponding author. E-mail address: lauradg@uw.edu. We thank Andrew Street
for helpful comments and invaluable advice during my stay with the Policy team at the
Center for Health Economics at the University of York. Also, we thank the Swiss National
Science Foundation for nancial support to the project. Any mistake is clearly our fault.
yInstitute of Economics (IdEP), Università della Svizzera italiana (USI); Swiss Federal
Institute of Technology in Zurich (ETHZ), Switzerland.
zDepartment of Engineering, University of Bergamo, Italy; Institute of Economics
(IdEP), Università della Svizzera italiana (USI), Switzerland.
1 Introduction
Ensuring good quality of care to nursing home (NH) residents is a major
concern in many health care systems. Actions to boost quality must take
into account cost containment measures required to manage increasing health
expenditures and ageing population. This twin objective of the NH sector
- high quality and a¤ordable costs - calls for better understanding of the
potential trade-o¤ between costs and quality. Quality aspects need to be
integrated in the empirical evidence of NH costs.
The literature on NH costs is extensive, but marginally addresses quality
of care. Most of the studies do not include measures of quality. Some of them
use imprecise or indirect measures, such as the number of deciency citations,
information about sta¢ ng or mortality rates. Others rely on modeling quality
as a latent variable (Gertler and Waldman, 1992; Carey, 1997). Finally, the
majority of these studies use cross-sectional designs and do not account for
unobserved heterogeneity that may a¤ect both costs and quality. Concerns
arise because failure to account for quality in cost functions is responsible for
omitted variable bias (Braeutigam and Pauly, 1986). This bias is even more
severe when comparing individual e¢ ciency levels, as these techniques are
particularly sensitive to model misspecication (Newhouse, 1994; Cremieux
and Ouellette, 2001).
Donabedian (1988) conceptualizes the measurement of quality in the NH
sector in terms of three dimensions: Structure, Process and Outcome (SPO).
The SPO framework is widely accepted in empirical analyses of quality. In-
ability to include information about these three dimensions of care are due
to measurement deciencies and limitations in data availability. Recently,
the introduction of the Resident Assessment Instrument (RAI) in the U.S.
and some European countries, started a comprehensive and multidimensional
assessment of all NH residents health status. These data, also called Min-
imum Data Set (MDS), are used to develop a battery of clinical indicators
of quality that meet the taxonomy of the SPO model (Zimmerman, 1995;
2003). These indicators are categorized in two groups: indicators of quality
regarding process and indicators of quality regarding outcome of care. As
such, they o¤er a unique tool to measure and compare quality of NHs in
di¤erent domains of care (Berg et al., 2012). However, NH cost studies using
clinical quality indicators generally neglect the relationship between di¤er-
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ent quality dimensions. More e¤ort is needed to understand whether the
multidimensional nature of quality is better captured by single or combined
quality indicators.
A positive relationship between costs and quality is generally expected
when higher levels of quality can be provided only through more costly equip-
ment or additional sta¤ employment. However, adverse patient events may
be costly to treat because they involve additional resource utilization for ex-
tra care. The relationship between costs and quality may therefore depend on
the dimension considered. Better procedures are expected to increase costs,
while prevention of development of adverse outcomes may actually reduce
costs (Weech-Maldonado et al., 2006; Wodchis et al., 2007).
Through this paper, we investigate the relationship between quality and
costs in NH care and contribute to the existing literature in four main re-
spects. First, we use a cost function approach consistent with the economic
theory of health care production. Second, we incorporate quality measures
into the cost function based on the taxonomy of the SPO model, and dis-
entangle the impact of di¤erent dimensions of quality on costs. Third, we
conduct our analysis using both composite and single measures of quality.
Finally, to our knowledge, this is the rst study providing evidence on the
relationship between costs and quality in NH care using panel data, if we
exclude the approach by Wodchis et al. (2007) which does not specify a cost
function.
The remainder of the paper is organized as follows: Section 2 outlines how
quality for NH services can be measured and presents the SPO framework
more in detail. Section 3 reviews previous studies on the relationship between
costs and quality. Section 4 describes the dataset and discusses the choice
of quality indicators and the empirical strategy. Estimation technique and
results are presented in Section 5. Finally, some concluding remarks are
provided in Section 6.
2 Quality
2.1 Denition and measurement
No universal denition of quality exists in health research. The Institute
of Medicine (IOM, 2001) states that quality of care is the degree to which
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health services for individuals and populations increase the likelihood of de-
sired health outcomes and are consistent with current professional knowl-
edge.1 This denition has signicantly inuenced the literature on quality
and is very much related to the paradigm of quality proposed by Donabedian
(1988). His seminal article on the assessment of quality of care represents the
foundation of modern quality assessment, providing a framework of reference
with guidance validity. Donabedian proposed the so called SPO framework.
Structure is dened by the attributes of the setting in which care is provided,
such as material resources (e.g. equipment), human resources (e.g. sta¢ ng
levels) and organizational structure (e.g. payment system). Process refers to
the activities of practitioners to give care, such as making a correct diagnosis
and implementing the treatment accordingly. Outcome denes the change in
health status of the patient. The success of this paradigm lies in its broad
scope, which encompasses older and newer denitions of quality. Table 1
shows how di¤erent measures of quality used in the literature fall within the
dimensions of the SPO framework.
With the development of quality indicators derived from the RAI, clinical
measures of quality regarding process and outcome are now available. How-
ever, only a few countries have adopted the RAI. Many countries use di¤erent
systems to measure quality in the NH sector (Nakrem et al., 2009). Each
measure of quality has advantages and disadvantages, which are discussed
below. Some relatively old indicators (non-clinical) are still considered valid
and are often combined in empirical studies with clinical quality indicators
derived from the RAI.
Previous studies attempt to capture NH quality di¤erences mainly using
indicators of structure or indirect signals. Probably, the most recognized
indicator with current validity is the number of deciency citations (Castle
and Ferguson, 2010). Deciency citations have the advantage of representing
di¤erent dimensions of reduced quality but su¤er from detection bias due
to high variability in the use of citations among states/countries. Another
important indicator that is employed extensively in the literature is the use of
resources, in particular, information on sta¢ ng. While earlier studies focus
1Other well recognized denitions are provided by the UK Department of Health (1997),
the Council of Europe (1997), and the WHO (2000). For a detailed exposition of the most
inuential and known denitions of quality, see Legido-Quigley et al. (2008).
4
on sta¢ ng levels as determinant factors (McKay, 1989; Farsi et al., 2005;
Farsi et al., 2008), recent studies recognize the need to extend this dimension
to sta¤ characteristics, such as sta¤ turnover, worker stability and skill levels
(Castle and Engberg, 2005; Castle and Engberg, 2007; Dormont and Martin,
2012; Spilsbury et al., 2011), as well as willingness of leadership (Rantz,
2004). A recent systematic review of Bostick et al. (2006) shows not only
evidence of association between higher licensed sta¤ and quality, but also a
signicant relationship between sta¤ turnover and quality indicators such as
pressure ulcers, weight loss and functional ability.
2.2 Concerns about quality indicators
The advantages and disadvantages of quality indicators based on the SPO
model are discussed in Castle and Ferguson (2010). Structural indicators
have the advantage of being easy to measure and data are often available.
The disadvantage is that the presence of structural attributes does not imply
their best use. Castle and Ferguson (2010) maintain that structural quality
indicators are necessary but not su¢ cient. Indicators of process are usually
easy to interpret as they inform on the provision of a particular treatment.
Even in this case, it cannot be determined whether or not the provided
treatment is appropriate. Finally, outcome indicators are of natural interest,
as they measure the change in patientshealth status. The main problem
with these indicators is that it is extremely di¢ cult to isolate the e¤ect of care
and changes in health, as the latter may be inuenced by many uncontrolled
factors.
The recent development of clinical quality indicators has improved the
measurement of quality, but with some limitations. Firstly, due to the ab-
sence of a universally accepted denition of quality, the selection of quality
indicators to include in empirical analyses is, to some extent, arbitrary. This
is an issue because of the usually low correlation among quality indicators.
Indeed, facilities with excellent outcomes in some dimensions may perform
poorly in others. The choice of indicators may therefore a¤ect the percep-
tion of NH quality. Secondly, detection bias occurs if higher quality NHs
are the more vigilant in looking for and detecting quality issues (Mor et al.,
2003). Since NH sta¤rather than an independent authority assesses residents
health status, risk of detection bias exists. Thirdly, variation in clinical qual-
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ity indicators may be due not only to changes in quality, but also in risk or
error (Arling et al., 1997). To cope with this issue, di¤erent risk-adjustment
techniques are used. While rst studies of NH quality mainly use adjust-
ment methods at the facility level (Nyman, 1988; Zinn et al., 1993a; 1994),
more recently risk-adjustment is performed at the individual level when data
are available. Di¤erent approaches include stratication, covariate models
(Mukamel, 1997) and standardization (Zinn et al., 1993b). For some clinical
indicators of quality that are considered particularly relevant in detecting the
presence of problematic cases of quality shortcomings, no risk-adjustment is
required. Among these are the presence of daily physical restraints (Berg et
al., 2002), dehydration and fecal impaction (Arling et al., 1997; Karon et al.,
1999). The main issue of risk-adjustment techniques is that they may only
partially capture residents risk factors, resulting in biased estimates of qual-
ity coe¢ cients (Mukamel et al., 2008). Risk-adjustment is also of concern
when risk-adjustment factors are themselves a function of quality. In these
cases, quality scores could be over-adjusted, giving credit for poor quality
(Mukamel et al., 2008).
3 Empirical evidence on the impact of quality
on costs
Empirical models using non-clinical quality measures mainly focus on the
impact of specic factors on costs, such as market structure, forms of orga-
nization, or reforms implemented in the NH sector. Quality measures are
usually introduced as control factors. Some of these studies use sta¢ ng in-
formation (e.g. Di Giorgio et al., 2014; Dormont and Martin, 2012; Farsi
et al., 2008; Konetzka et al., 2004) or deciency rates (e.g. Harrington et
al., 2001). Another strand of literature exploits determinants of quality vari-
ability. Factors considered include the impact of state regulations (Bowblis
et al. , 2012; Bowblis and Lucas, 2012), ownership form (Grabowski et al.,
2013; Spector et al., 1998), competition (e.g. Brekke et al., 2010; Castle et
al., 2008; Forder and Allan, 2011; Grabowski, 2004; Starkey et al., 2005) and
nancial performance (Gutacker et al., 2013).
We focus our review on studies that use clinical indicators derived from
the RAI to investigate the relationship between costs and quality. The main
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contribution of these studies is summarized in Table 2, where details on
the choice of quality indicators, the empirical approach and the results are
presented.
Mukamel and Spector (2000) is one of the rst studies investigating the re-
lationship between costs and quality using the RAI-derived quality indicators.
The authors estimate a variable cost function for NHs in New York State.
Three indicators of outcome quality are included: activity of daily living,
pressure ulcers and mortality. Regression-based risk adjustment (Mukamel,
1997) is applied and weighted ordinary least-squares are used to tackle the
issue of di¤erent sample size in the calculation of outcome variables.2 The
authors report an inverted U-shaped relationship between costs and quality,
although only few coe¢ cients are statistically signicant. The loss of statis-
tical signicance is attributed to high multicollinearity among higher-order
terms of quality indicators. Due to the availability of only weak instruments,
the endogeneity issue of quality is ignored.
An important contribution to the cost-quality relationship is provided by
Laine et al. (2005a, 2005b) who implement stochastic frontier models. In
these studies, endogeneity of quality is not addressed. The rst study models
a stochastic production frontier for the Finnish long-term care sector in 2001
where the dependent variable is specied as the case-mix weighted patient
days and covariates include only input characteristics. Ward characteristics
and quality are modeled following Battese and Coelli (1995), i.e. techni-
cal ine¢ ciencies are specied as a function of quality indicators. Quality is
measured linearly by three continuous indicators: the prevalence of high-risk
pressure ulcers, the prevalence of weekly use of depressants and hypnotics,
and the prevalence of depression with no treatment. The latter two indi-
cators are not risk adjusted. The prevalence of pressure ulcers is the only
quality indicator signicantly associated with technical ine¢ ciency. The sug-
gested relationship is that higher prevalence of pressure ulcers leads to higher
technical e¢ ciency.
Laine et al. (2005b) provide a similar cross-sectional analysis which shifts
the focus from productive e¢ ciency to cost e¢ ciency. The analysis is per-
formed using data at the ward level obtained aggregating individual-level
data. The authors include quality indicators regarding process, i.e. the
2The authors use the inverse of the squared root of the sample size as weights.
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prevalence of depression without treatment and prevalence of pressure ulcers
adjusted for risk, in the deterministic part of the cost frontier. Indicators of
output quality, i.e. the prevalence of depressants and hypnotics use and the
prevalence of restraint use, are modeled following Battese and Coelli (1995).
The mean values of the indicators over a three-years period is taken without
risk adjustment. The underlying idea is to allow indicators of process qual-
ity to a¤ect the production process itself, while the outcome is restricted to
have an impact on the level of ine¢ ciency. The results show that a worse
outcome in terms of higher prevalence of pressure ulcers is associated with
higher costs, while poor process quality measured by the weekly use of de-
pressants and hypnotics is associated with higher ine¢ ciency. However, the
impact of these quality indicators is relatively low.
Weech-Maldonado et al. (2006) investigate the impact of quality on costs
in U.S. NHs. Using cross sectional data from around 750 facilities, they test
the inverted U-shaped theory by adding squared and cubic terms of qual-
ity. Quality is measured by changes in physical and psychological outcome
indicators, i.e. worsening pressure ulcers and mood decline. Indicators are
adjusted for risk using the covariates model (Mor et al., 1998). A weighted
two-stage least squares regression is estimated to address endogeneity of qual-
ity indicators. Socio-demographic characteristics at the county level as well
as the presence of alternative service providers are used as instruments for
quality scores. However, the validity of these instruments is not tested. The
results show an inverted U-shaped relationship between costs and pressure
ulcers. An opposite pattern arises for mood decline, showing that di¤erent
indicators of quality may lead to di¤erent types of relationships.
Additional evidence based on data from Ontario, Canada, is provided
by Wodchis et al. (2007). The authors estimate individual-e¤ects mod-
els where total costs are regressed on output, labor price, some exogenous
variables and quality indicators adjusted for risk using a resident-level co-
variates model.3 Heteroskedasticity, autocorrelation and endogeneity issues
are discussed. However, due to the lack of a valid instrument, endogeneity
is ignored. The analysis shows a negative relationship between costs and use
of daily physical restraints, as well as worsening incontinence. Antipsychotic
use, the prevalence of pressure ulcers and the prevalence of severe pain are
3As an exception the prevalence of physical restraint use is not risk adjusted.
8
not statistically signicant.
Most of the studies presented above nd correlation between some quality
indicators and costs. However, the association is weak and the approaches
used are hardly comparable. As suggested in the Introduction, the majority
of these studies use a cross-sectional design and do not account for unob-
served heterogeneity that may a¤ect both costs and quality. The only excep-
tion is the study by Wodchis et al. (2007). Unobserved heterogeneity may
represent a serious problem in analyses of costs-quality relationship due to
the di¢ culty in measuring quality. If the risk-adjustment technique used in
cross-sectional studies does not capture the facility-specic features perfectly,
then the results may be biased. Also, only few studies address the potential
endogeneity of quality, and virtually no test is provided on the validity of the
instruments.
In the following section we propose an empirical approach to investigate
the relationship between costs and quality using data from Swiss NHs. The
main novelty of this approach is the inclusion of process and outcome quality
measured by composite or single quality indicators into a cost function. As
compared to previous studies, we are also able to control for unobserved
heterogeneity by exploiting the panel structure of our data.
4 Model specication and data
4.1 Choice of quality indicators
Quality indicators measure adverse events such as the use of antipsychotic
drugs, injuries, bedfast residents, and pressure ulcers. To select appropri-
ate quality indicators from the 22 available in our dataset we consider two
approaches. The rst approach combines quality indicators to obtain com-
posite measures of process and outcome quality, which are then plugged into
a cost function. The second approach is based on the selection of single qual-
ity indicators of process and outcome directly included in the cost function.
Clearly, both approaches have advantages and disadvantages.
Combining di¤erent quality indicators, as suggested for instance by the
U.S. Institute of Medicine (2006), allows us to condense the multidimensional
nature of quality, limit the number of variables included in an econometric
model, and overcome possible arbitrariness in the choice of quality indica-
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tors. Though, combining di¤erent quality indicators requires a weighting
mechanism, which is subject to critics. Di¤erences in the number of eligible
residents for di¤erent quality events across facilities may represent a seri-
ous problem in obtaining a composite measure of quality. To overcome this
problem, quality indicators can be adjusted before aggregation to increase
comparability across facilities. The avoidable number of residents potentially
exposed to di¤erent quality events may o¤er a valid solution for adjustment.
A slighly more sophisticated approach relies on the generation of adjusted
indicators using a principal component analysis (PCA). Still, composite mea-
sure of quality makes it di¢ cult to identify the factors a¤ecting costs. To
address this issue, we rely on Donabedians classication of quality and de-
rive separate composite indicators for both process and outcome. This allows
us to identify the e¤ect of the two quality dimensions separately.
To derive composite indicators of process and outcome quality (Qprocess
and Qoutcome) we use two methods. First, we weight each quality indicator
by the number of residents exposed to a given quality event within each NH.
The second approach applies a principal component analysis using all quality
indicators to obtain two composite measures of process and outcome quality.4
This statistical procedure accounts for possible correlation between di¤erent
quality indicators through an orthogonal transformation which obtains values
of linearly uncorrelated quality indicators called principal components. Each
succeeding component has the largest possible variance in the data. We look
at the second principal component to get adjusted quality indicators which
are then aggregated to derive composite measures of process and outcome
quality.
As stated above, the second approach to select appropriate quality in-
dicators is based on single quality indicators. Single quality measures are
probably more reliable and meaningful than composite measures. However,
a selection process is needed to limit the number of indicators used in an
econometric model. Our selection process is built on three strands of litera-
ture. First, we consult the medical recommendations on the pertinence of the
indicators to reveal quality issues in NHs. Second, we consider studies on the
4The large majority of our quality indicators include 173 observations. However, for
few of them information was collected only for two years. To maximize the number of
observations used in the following econometric analysis, we dropped four single quality
indicators with missing values (see Table 4 for details).
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technical requirements that quality indicators need to satisfy to be included
in empirical analyses. And nally, we look at previous studies investigat-
ing the relationship between costs and quality using the quality indicators
analyzed by Zimmerman (1995).
From the medical literature we consult the numerous lists of recommended
indicators to use in benchmarking analyses of NHs (Berg et al., 2002; Mor
et al., 2003; Rantz et al., 2004). From the medical-statistical literature, we
derive three main criteria that should be satised for the empirical analysis
(Berg et al., 2002; Laine et al., 2005b): a relatively large variation in the
quality scores, the absence of multicollinearity between the indicators and
other variables, and a relatively large number of observations from which the
quality indicators are calculated. The issue of the denominator is motivated
by statistical properties since some quality indicators capture the onset of
rare events. In these cases, the relevant question is whether the observed
frequency of the event can be considered as a true score, or it is driven by
random shocks. Indeed, standard errors of rare events are large and gener-
ate problems in the comparison of quality among facilities. The minimum
number of observations for benchmarking is twenty (Berg et al., 2002).
Based on these criteria, we select two process quality indicators and two
outcome quality indicators. The two indicators of process are the presence
of antipsychotic use for low-risk residents (Qantips) and the presence of daily
physical restraints use (Qrestr). The two indicators of outcome include the
prevalence of weight loss (Qweight) and the prevalence of severe pain (QPain).
Finally, we control for time-invariant quality aspects regarding the structure
of NHs through the econometric specication of the model (see section 5).
4.2 Detailing the cost function
In order to identify the impact of quality on costs, we consider a cost model
which includes quality indicators as derived in section 4.1. Total costs are a
function of output (Y ), measured by the number of patient-days of NH care,
prices for labor, capital and material (Pl, Pk, Pm), the institutional form of
the NH (IF ), the case-mix of residents (MIX), the nursing sta¤ ratio (SR),
a vector of process and outcome quality indicators (q), and a time trend ()
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which captures technological progress:5
C = f(Y , Pl, Pk, Pm, IF , MIX, SR, q, ). (1)
The price of labor is calculated as the weighted average wage of di¤erent
professional categories employed in the NH (doctors, nurses, administrative
and technical sta¤). We choose to include only one price of labor to avoid
multicollinearity problems that typically arise with labor prices for di¤erent
categories. The price of capital is calculated as the sum of mortgage costs,
amortization and costs related to capital purchases divided by the capital
stock, which is approximated by the number of beds. The price for material
and meals is computed by taking the remaining costs and dividing them by
the number of meals provided each year. This item mainly includes costs for
food, energy and administrative costs.
The main di¤erence among nonprot NHs lays in their institutional form.
Public-law NHs are public administrative units without a separate judicial
status from the local public administration . Conversely, private-law NHs
usually take the form of a foundation. Since the decision-making process may
vary across institutional forms, we include a dummy for the institutional form
(IF ) equal to one when the NH is a public-law organization, and 0 otherwise.
SR is the nursing sta¤ ratio, i.e. the ratio between the number of nurses
employed in a NH and the number of nurses that should be employed ac-
cording to the guidelines of the regulator (optimal amount of sta¤). Because
nursing care is a labor-intensive service, sta¢ ng levels have been recognized
as a good indicator for (structure) quality (Bostick et al., 2006). Note, how-
ever, that our indicator is conceptually di¤erent from other quality indicators
related to sta¤ levels since it captures deviations from the optimal number
of nurses.
The vector of process and outcome quality indicators (q) leads to three
di¤erent model specications. In Model 1, the quality vector includes two
composite indicators (Qprocess and Qoutcome) derived from PCA. Similarly, in
Model 2 the quality vector is represented by two composite indicators de-
rived using weights according to the number of residents exposed to di¤erent
5In a non-competitive environment such as the Swiss one, there is no reason to assume
that NHs minimize costs. In this case, the estimated costs function is a behavioral cost
function(Evans, 1971) and can still be used to make a comparison among rms.
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quality aspects. Finally, Model 3 includes a vector of 4 single quality mea-
sures: two process quality indicators - the prevalence of antipsychotic use for
low-risk residents (Qantips) and daily physical restraints use (Qrestr) - and two
outcome quality indicators - weight loss (Qweight) and severe pain (Qpain).
Qantips is risk-adjusted based on the stratication approach, whereas
Qrestr is a sentinel indicator and as such no risk-adjustment is required (Berg
et al., 2002). Due to lack of data at the resident level, we further control
for case-mix di¤erences using an index at the facility level (MIX). This
index measures average patientsassistance need by means of normal daily
activities such as eating, personal care or physiological activities and is cal-
culated on yearly basis by the regulator. Patients are classied in one out
of ve categories according to their severity level. A value between 0 and 4
is assigned where higher values indicate more severe cases.6 We expect this
case-mix indicator to be correlated with patientsrisk factors that are not
observable. Moreover, any unobserved facility-specic risk factors feature is
captured by the individual e¤ects. We acknowledge that the risk-adjustment
system used in this analysis may be less precise than adjustments based on
clinical information at individual level. However, as previously discussed,
even complex systems of risk adjustments present serious shortcomings.
For the estimation of the cost model in (1), we use a log-log functional
form. This implies that cost elasticities are not allowed to vary with output.
When choosing the functional form, parsimony in the number of coe¢ cients
to be estimated is traded o¤ against exibility. A translog functional form
would require interacting all quality indicators with the production factors.
The number of parameters to be estimated would expand to (n+1)(n+2)=2,
where n is the number of covariates, leading to an important loss of degrees
of freedom.7
Input prices and total costs are divided by the material price in order to
6Note that this is not the RUGs classication system of residents. As compared to the
RUGs system, our case-mix measure is not derived from the MDS. The main advantage
is that case-mix di¤erences are less likely to reect quality levels.
7In a preliminary analysis, we also estimated: 1) a full-translog cost model and 2) a
hybrid translog cost model. In the hybrid translog cost function quality indicators were
included only in linear form. The results of the full translog were not satisfactory, probably
due to multicollinearity problems and the loss of degrees of freedom. The results of the
hybrid cost function were very similar to those obtained with the log-log functional form.
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satisfy the homogeneity condition in input prices.8 The log-log form of eq.
(1) is:
ln

C
Pm

= 0 + Y lnY + Pl ln
Pl
Pm
+ Pk ln
Pk
Pm
+ IF IF (2)
+MIX lnMIX + SRSR + qq+ t + ",
where q is the vector of quality parameters, " is the error term which contains
individual e¤ects i. The individual subscript i and the time subscript t are
omitted for simplicity.
The estimation of the cost function in (2) is based on the assumption
that output, input prices and quality are exogenous variables. In the case of
NHs included in the sample, output is likely to be exogenous because NHs
have to accept all residents in a given residential area and residents do not
have free choice of the facility. Also, the excess of demand due to subsidized
prices leads to occupation rates of about 100%. For the same reasons, also
the case-mix is likely to be exogenous. Moreover, the reimbursement system
is linked to the NH-specic case-mix, which limits incentives to attract less
costly patients. Input prices can be considered exogenous because NHs have
to follow the guidelines imposed by the regulator.
As with respect to quality, it is important to distinguish between the
nursing sta¤ ratio and clinical quality indicators derived from the RAI. The
nursing sta¤ratio is strongly regulated by the canton and NHs are not allowed
to deviate signicantly from the optimal sta¤ size. Therefore, we can exclude
the presence of endogeneity.9 The potential endogeneity issue of unregulated
clinical indicators will be discussed later in section 5.
4.3 Data and descriptive statistics
We merge two datasets on costs and quality of NH residents in Southern
Switzerland (canton of Ticino), which were provided by the regulator. The
rst dataset includes yearly use of resources at the organization level ex-
tracted from the annual reports of NHs. It includes 45 NHs over a 10-years
8The cost function is linear homogenous of degree 1 in input prices when a 10% increase
in all input prices leads to a 10% increase in total cost.
9The Durbin-Wu-Hausman test performed using the lagged SR as instrumental variable
does not reject exogeneity at the 99% level.
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period, from 2001 to 2010. The second dataset contains information derived
from the MDS on 22 quality indicators at the organization level for the period
2006-2010, excluding the year 2008. These indicators measure the presence
of adverse events in the facility.10 Due to missing values in the dataset, no
quality scores are available for three NHs for the years 2006 and 2007. Com-
plete data pertaining to 45 NHs observed over a 4-years period (2006, 2007,
2009 and 2010) are used. The total number of observations is 173 for the
models with composite quality indicators. For the model with single quality
indicators we exclude observations with denominator of the quality scores
smaller than 20. This leads to a loss of 10 observations.
In tables 3 and 4 we provide descriptive statistics for the main costs and
quality variables. The data show that on average a resident day costs 247
Swiss francs (SFr.). The di¤erence between the minimum and the maximum
cost is almost SFr. 200. This may be due to di¤erences in the output, as the
number of resident days ranges between almost 9000 and more than 64000.
The average resident case-mix is 3:1, with important di¤erences among NHs
(0:80-3:83). The average price of labor is approximately SFr. 81000, and NHs
are highly homogenous in this respect. The prices of capital and material
show higher variation, from SFr. 1054 to almost SFr. 23000 and from SFr.
5:16 to around SFr. 103, respectively. These di¤erences are due to renova-
tion or enlargement investments. At the approximation point, the shares of
capital, material and labor costs are 6:5%, 12:1% and 81:4%, respectively.
Regarding quality indicators, the data show that the nursing sta¤ ratio is
very close to 1, as expected. Variations larger than 10% are possible only for
very short periods. On average, 32% of low-risk patients use antipsychotics,
but in some NHs this value reaches 88%, suggesting that serious problems
may exists within the production process of NH care. The average prevalence
of daily physical restraints use is around 20%, and ranges between 0and
50%. Regarding outcome quality, the average prevalence of residents who
lost weight unexpectedly is about 7%, and this percentage ranges between
0 and 27%. Finally, the prevalence of residents su¤ering from severe pain is
21% on average, but reaches more than 60% in some cases.
10Four of these indicators are risk adjusted based on the stratication approach. This
means that they are calculated separately for high-risk and low-risk patients. In these
cases, we use the low-risk indicators.
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An interesting question is whether quality domains are correlated. This
may a¤ect the selection process of appropriate composite quality scores as
well as the choice of single quality indicators to be included in the economet-
ric analysis. We compute the correlation among indicators (including the
sta¤ ratio) and Kendalls rank correlation coe¢ cient (Kendall, 1955). The
latter measures the similarity of the ordering of NHs when these are ranked
according to quality scores. Both measures indicate a very low correlation
between quality indicators (< 25%). Furthermore, we are condent that
the derivation of composite quality indicators using orthogonal components
(Model 1) and the selection process of a small number of single quality in-
dicators (Model 3) explained in section 4.1 ensure that collinearity between
quality scores is not an issue in our regressions.
5 Econometric estimation and results
To analyze the impact of process and outcome quality on costs we use panel
data models. The FE model treats the individual e¤ects as xed parameters.
These are allowed to be partially correlated with regressors, thus accommo-
dating a limited form of endogeneity (Cameron and Trivedi, 2010). This
feature is particularly appealing in studies of costs-quality relationship due
to the potential endogeneity of the indicators. The Hausman test rejects
the null hypothesis of no correlation between the individual-e¤ects and the
covariates at 5% signicance level. Given that the percentage of within vari-
ation of the variables of interest as with respect to the overall variation is
satisfactory, the FE estimates should be fairly precise (Cameron and Trivedi,
2005). Therefore, the FE model represents our preferred estimator. The re-
sults of the estimation of the three models with combined and single quality
indicators described in section 4.2, are reported in Table 5.
Standard errors are corrected using the cluster-robust estimator based on
Stock and Watson (2006) in all models. These authors show that the cluster-
robust estimator is preferred in FE models if serial correlation is expected,
and it is reasonable to rely on asymptotic theory. In our sample, each cluster
contains a su¢ cient number of observations so that clustered standard errors
are preferred (Kezdi, 2004).11
11Kezdi (2004) states that a sample of 50 clusters is close enough to innity for accurate
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The estimated parameters are very similar across the three models. The
coe¢ cient of output (Y ) is positive and smaller than 1, suggesting that an
increase in output by 10% increases total costs by roughly 7%. As expected,
more severe patients (MIX) are more costly to treat. The share of labor
costs (Pl) is estimated at around 91%, while the estimated share of capital
(Pk) is between 6% and 7%. The form of organization (IF ) is dropped in
the FE regressions because of time invariance, whereas it does not seem to
a¤ect total costs in the OLS and the RE regressions.
Consider now the main variables of interest: quality indicators. The
nursing sta¤ ratio (SR) is highly signicant. As expected, the higher the
relative number of nurses working in a NH, the higher the costs. The esti-
mated coe¢ cient is stable across the three models. In Model 1 and Model 2,
we consider two composite quality indicators (Qprocess and Qoutcome). Note
that outcome quality exhibits a positive and signicant e¤ect on costs in
both models although the magnitude of the e¤ect is stronger when compos-
ite quality indicators are derived using weights according to the number of
residents exposed to di¤erent quality aspects (Model 2). Conversely, process
quality shows an opposite (negative) e¤ect on costs, although the impact is
not signicant. These results are in accordance with those obtained with
single quality measures (Model 3). We observe a positive and signicant
association between costs and outcome quality measured by the prevalence
of weight loss (Qweight) and the prevalence of severe pain (Qpain). Instead,
process quality measured by the use of daily physical restraints (Qrestr) and
the prevalence of antipsychotic use for low-risk residents (Qantips) does not
seem to have a signicant impact on costs. The former indicator (Qrestr)
is, however, slightly associated with lower costs in OLS and RE regressions
reported in Table 6.
The time trend (t) is statistically signicant in Models 2 and 3 but the
coe¢ cient is very small. Total costs of NH care remained pretty constant
over the time period considered in the analysis.
Generally, all the estimated parameters are very similar across di¤erent
panel models, only slightly lower in the FE model. The OLS model does not
inference if the number of observations for cluster is not too small. A cluster is considered
small if it contains less than ve observations per cluster (Rogers, 1994). In our case, the
signicance of the coe¢ cients remains unchanged when standard errors are clustered.
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consider the unobserved heterogeneity. The similarity of the RE and the FE
estimates suggests a low correlation between the individual e¤ects and our
covariates.
5.1 Testing for endogeneity
We believe that, even in the unlikely possibility of quality endogeneity, the
potential bias in our estimates is very limited. This is because of the in-
stitutional setting of the NH sector and the strong regulation system. NHs
activities are regulated by the local government in a relatively e¤ective way.
Therefore, we can plausibly assume that NHs do not vary their levels of qual-
ity according to the cost of services. Nonetheless, in order to test potential
endogeneity, we consider instrumental variables approaches using the two-
stage least squares (2SLS) procedure and the e¢ cient generalized method of
moments (GMM) combined with the FE model. The GMM approach has
the advantage of consistency in the case of arbitrary heteroskedasticity and
shows higher exibility than 2SLS, in particular to test the validity of the
instruments. Both approaches come at the price of poor nite sample perfor-
mance, in particular in the case of weak correlation between the instruments
and the endogenous variable.12 The GMM approach is preferred since it al-
lows errors clustering for panel data and provides a battery of tests to check
the validity of the instruments.
A valid instrument must satisfy two requirements: the instrument z must
be correlated with the endogenous variable x, Cov(x; z) 6= 0, and uncorre-
lated with the error term u, Cov(z; u) = 0. In the case of multiple endogenous
regressors, the Shea partial R2 (Shea, 1997) measure should be used to test
the rst condition, as this takes into account the intercorrelation among the
instruments.13 However, this does not exclude the possibility of weak instru-
ments, which lead to a very high asymptotic bias. The second condition can
be tested when there are more instruments for an endogenous variable. In
12In particular, the e¢ cient GMM approach may su¤er from poor nite sample proper-
ties as the optimal weighting matrix of the e¢ cient GMM estimator is a function of fourth
moments, which require large sample size (Hayashi, 2000).
13The F diagnostic for weak instrument for the joint signicance of the instruments in
rst-stage regression does not recognize situations in which some instruments are good
while others are weak.
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this case, the C-statistic, also called di¤erence-in-Sarganstatistic, can be
used to test the orthogonality condition of a subset of instruments (Hayashi,
2000).
As shown in previous studies (Mukamel and Spector, 2000; Wodchis et
al., 2007), good instruments for quality are lacking. Moreover, nding good
instruments for several quality indicators is also very challenging. We rely
on three hypotheses. First, visits by residentsrelatives exert pressure on the
management sta¤ of the NH to keep adequate levels of quality. Hence, we
identify two variables: the weighted average distance (travel time) between
residentslocation and the NH facility, and the weighted population density of
the area served by the NH. The second hypothesis assumes that the quality
o¤ered by the NH depends on the average quality o¤ered by surrounding
NHs. We build a variable to capture pressure from other NHs located in
geographical proximity. For each year and NH, pressure is measured as the
average score of quality indicators of NHs located in neighbouring districts.14
Our third hypothesis is that the elderly population living in the area around
the NH exercise an indirect pressure on quality of home care provided. We
then consider the percentage of young, adult and elderly population in the
catchment area of each NH. Finally, we also consider lagged values of quality
indicators as natural instruments.15
Generally, our endogeneity tests do not reject exogeneity when using all
or part of the instruments dened above both with composite and single
quality indicators. However, the Shea partial R2statistics show that the per-
centage of variability in quality indicators explained by the instruments is
relatively low. Since our instruments are likely to be weak we cannot be
condent that the exogeneity of quality indicators is correctly assessed, and
therefore the Hausman test may be distorted. However, as explained by Hahn
et al. (2011), discussion about weak instruments is not completely clear in
the econometric literature. As stated above, addressing endogeneity using
14The region considered in the analysis is divided into 8 districts: Mendrisio, Lugano,
Vallemaggia, Locarno, Bellinzona, Riviera, Blenio and Leventina. Given that only few NHs
are located in northern districts, Vallemaggia, Leventina and Blenio are pooled together.
15Lagged values are an attractive instrument due to the high correlation with the en-
dogenous variable. Nevertheless, caution is necessary in the presence of serial correlation
in the data, as this may invalidate the instruments (Angrist and Kruger, 2001). To test
for autocorrelation in panel data set, we use the test developed by Wooldridge (Drukker,
2003; Wooldridge, 2002).
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multiple quality indicators and many instruments may not be very e¢ cient.
Consequently, we test exactly identied models with only one quality indica-
tor and one instrument. The null hypothesis that the excluded instruments
are exogenous cannot be rejected in all these cases and the results are robust
to weak identication. Although we are not able to econometrically exclude
that quality endogeneity is completely absent in the relationship between
costs and quality in NH care, we show evidence that our FE estimates are
unlikely to be a¤ected by quality endogeneity bias.
6 Conclusions
To ensure good quality of long term care while keeping costs under control, a
better understanding of the relationship between costs and quality is needed.
In the NH sector, quality improvements represent a main concern since the
ageing of the population is putting the system under nancial pressure.
In this paper, we investigated the relationship between costs and qual-
ity according to the SPO-framework developed by Donabedian (1988). We
used recently published data on quality indicators derived from the resident
assessment instrument (RAI) and costs of Swiss NHs. In addition to struc-
ture quality indicators (e.g. nursing sta¤ ratio), we considered composite
and single measures of process and outcome quality. Composite indicators of
process and outcome quality were obtained by aggregating 22 single quality
indicators using i) NH-specic weights based on residents exposed to di¤er-
ent quality aspects or ii) a principal component analysis. Alternatively, a
limited number of single quality indicators capturing process and outcome
quality was selected.
To disentangle the impact of di¤erent dimensions of quality on costs, we
incorporated quality measures into a cost function. As compared to previous
studies, we estimated individual-e¤ects models based on panel data that al-
lowed to control for unobserved heterogeneity. Our analyses showed evidence
of a positive and signicant relationship between clinical indicators of out-
come quality (e.g. the prevalence of severe pain and the prevalence of weight
loss) and total costs. Conversely, the impact of process quality indicators
was unclear. For instance, higher prevalence of daily physical restraint use
was associated to lower costs, while the use of antipsychotics was positively
related to costs, but these e¤ects were only weakly signicant. Finally, struc-
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ture quality indicators such as sta¢ ng levels were strongly associated with
higher costs. We did not nd evidence of quality endogeneity bias.
From a policy point of view, a correlation between costs and quality may
suggest that quality aspects should be incorporated in funding schemes de-
signed for NH care. Accounting for this correlation may allow the regulator to
rene economic incentives taking into account the trade-o¤ between quality
and costs.
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Structure Process Objective outcome Subjective outcome
Room size Sta¢ ng information Mortality rates Resident satisfaction
Equipment Mistakes rate Hospitalization Family satisfaction
Sta¢ ng levels Deciency citations RAI quality indicators Deciency citations
Residents case mix RAI quality indicators
Table 1: Classication of quality indicators according to the SPO-framework
developed by Donabedian (1988).
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Variable Description Obs Mean SD Min Max
C Average cost (SFr./Y ) 440 246.90 25.66 179.48 377.52
Y Annual resident days 519 25434 10231 8955 64275
Pl Average labor price in SFr. per 519 80817 5196 63363 97512
employee per year
Pk Average capital price in SFr. per 440 5735 2528 1054 22981
bed
Pm Average material price in SFr. 440 9.23 4.74 5.16 103.25
per meal
MIX Average dependency index 519 3.10 0.34 0.80 3.83
SR Nursing sta¤ ratio 519 0.96 0.09 0.74 1.55
Notes: All monetary values are in 2005 Swiss francs (SFr.), adjusted by the national Consumer Price
Index.
Table 3: Descriptive statistics of costs, output and structure variables.
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Quality indicator Description Obs Mean SD Min Max
PROCESS
QdepressionNT PR of depression symptoms 173 31.45 12.54 3.6 60.0
without treatment
Qdrugs Prevalence of use of 9 173 41.46 14.30 0.0 75.0
or more medications
Qcatheters INC of indwelling catheters 173 5.38 5.25 0.0 27.9
Qgavage PR of enteral feeding 130 1.46 2.67 0.0 17.5
QantipsyHR PR of antipsychotic use - HR 173 51.47 23.22 0.0 100.0
QantipsyLR PR of antipsychotic use - LR 173 31.67 12.45 7.7 87.5
Qrestraints PR of daily physical restraints 173 19.56 9.76 0.0 50.0
Qactivity PR of little or no activity 173 52.73 19.74 6.7 100.0
Qprocess Composite indicator (using No. exposed) 173 25.83 5.01 12.9 40.3
Composite indicator (using PCA) 130 0.00 1.15 -3.6 3.2
OUTCOME
Qinjuries INC of injuries 159 2.39 6.64 0.0 50.0
Qfalls PR of falls 173 9.20 5.70 0.0 24.4
QbehaviourHR PR behavior problems - HR 173 34.44 13.80 0.0 78.9
QbehaviourLR PR behavior problems - LR 173 15.30 13.33 0.0 70.0
Qdepression PR of depression symptoms 173 56.41 16.47 14.8 100.0
QincontinenceHR PR of bowel incontinence - HR 173 80.23 19.86 0.0 100.0
QincontinenceLR PR of bowel incontinence - LR 173 30.54 19.40 0.0 100.0
Qincontinence PR of bladder incontinence 173 59.88 25.91 0.0 100.0
without a toileting plan
Qweight PR of weight loss 173 6.75 5.10 0.0 27.3
Qbedfast PR of bedfast residents 172 8.48 6.75 0.0 29.6
Qlos Incidence of decline in late- 154 30.79 26.12 0.0 100.0
loss activities of daily living
QulcersHR PR of pressure ulcers - HR 173 11.67 9.24 0.0 50.0
QulcersLR PR of pressure ulcers - LR 173 2.90 5.01 0.0 28.6
Qpain PR of important pain 173 21.24 11.99 0.0 61.1
Qoutcome Composite indicator (using No. exposed) 173 17.68 4.08 6.8 28.6
Composite indicator (using PCA) 153 0.00 1.16 -2.7 3.0
Notes: INC=incidence, PR=prevalence, HR=high-risk, LR=low-risk
Table 4: Descriptive statistics of process and outcome quality indicators.
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Model 1 Model 2 Model 3
Composite quality indicators Single quality indicators
using PCA using No. exposed
Coef. Std. Err. Coef. Std. Err. Coef. Std. Err.
Constant -3.212 0.470 -3.477 0.505 -3.621 0.541
Y 0.718 0.038 0.736 0.041 0.751 0.046
Pl 0.907 0.025 0.911 0.025 0.916 0.026
Pk 0.068 0.015 0.067 0.015 0.059 0.015
MIX 0.203 0.065 0.202 0.064 0.219 0.079
SR 0.464 0.059 0.482 0.066 0.480 0.071
Qprocess -0.002 0.004 -0.048 0.070
Qoutcome 0.006 0.003 0.240 0.094
Qantips 0.026 0.025
Qrestr -0.064 0.042
Qpain 0.056 0.027
Qweight 0.102 0.043
t 0.003 0.002 0.006 0.002 0.005 0.002
R2 0.977 0.977 0.980
N 173 173 163
Notes: Signicance levels: * = 10%, ** = 5%, *** = 1%.
Table 5: Estimated coe¢ cients of xed e¤ects models with composite and
single quality indicators.
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Model 3 (Single quality indicators)
OLS Random e¤ects
Coef. Std. Err. Coef. Std. Err.
Constant -4.546 0.439 -4.657 0.328
Y 0.875 0.017 0.853 0.019
Pl 0.874 0.040 0.910 0.027
Pk 0.062 0.015 0.059 0.013
IF -0.009 0.014 -0.007 0.015
MIX 0.277 0.081 0.254 0.060
SR 0.485 0.089 0.513 0.069
Qantips 0.033 0.054 0.034 0.025
Qrestr -0.119 0.048 -0.071 0.040
Qpain 0.076 0.046 0.061 0.028
Qweight -0.061 0.087 0.098 0.044
t 0.003 0.002 0.006 0.002
R2 0.984 0.982
N 163 163
Notes: Signicance levels: * = 10%, ** = 5%, *** = 1%.
Table 6: Estimated coe¢ cients of OLS and random e¤ects models with single
quality indicators.
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